<DOC>
	<DOCNO>NCT00213083</DOCNO>
	<brief_summary>The purpose study determine whether Carraguard® Gel prevent transmission HIV use vaginal intercourse , confirm gel safe vaginal use .</brief_summary>
	<brief_title>Efficacy Study Vaginal Gel Carraguard Prevent HIV Transmission</brief_title>
	<detailed_description>This study design show Carraguard® protect woman HIV use sex , safe long-term use .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Sexually Transmitted Diseases</mesh_term>
	<mesh_term>HIV Seropositivity</mesh_term>
	<mesh_term>Anti-Infective Agents</mesh_term>
	<criteria>HIV negative agree test HIV tell result visit study Aged 16 40 year age Have least one vaginal intercourse within last three month Willing able give write informed consent ( desire , consent provide parent guardian write assent minor participant ) Provide locator information study staff throughout trial Comply aspects study protocol , include random assignment Carraguard® plus condom placebo plus condom arm , clinical valuation , specimen collection testing , visit schedule study drug regimen Citizen permanent resident South Africa Resident past year intend reside catchment area site next two year During study , use vaginal product except tampon prescribe approve study clinician . Currently pregnant , indicate desire become pregnant next two year time screen Within four week last pregnancy outcome time enrolment Pap smear screen grade carcinoma . Injected illicit drug 12 month prior screen Participating clinical trial/HIV prevention study</criteria>
	<gender>Female</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>Microbicide</keyword>
	<keyword>HIV</keyword>
	<keyword>AIDS</keyword>
	<keyword>STIs</keyword>
	<keyword>STDs</keyword>
	<keyword>Efficacy</keyword>
	<keyword>HSV</keyword>
	<keyword>Women</keyword>
	<keyword>South Africa</keyword>
	<keyword>seroconversion</keyword>
	<keyword>condom</keyword>
	<keyword>safe-sex</keyword>
	<keyword>vaginal intercourse</keyword>
	<keyword>prevention</keyword>
	<keyword>HIV Seronegativity</keyword>
</DOC>